Danavorexton (TAK-925): an orexin receptor 2 agonist as a new 'arousal' agent.
Br J Anaesth
; 132(3): 466-468, 2024 Mar.
Article
em En
| MEDLINE
| ID: mdl-38346840
ABSTRACT
A preclinical study in animals has further characterised a new 'arousal' agent. Danavorexton (TAK-925) is an agonist for orexin receptor 2 where it promotes recovery from inhalational and i.v. anaesthesia and opioid sedation. Although danavorexton reverses opioid sedation, it does not compromise analgesia. This could be a useful addition to the postoperative drug cupboard.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Piperidinas
/
Nível de Alerta
/
Sulfonamidas
/
Analgésicos Opioides
Limite:
Animals
Idioma:
En
Revista:
Br J Anaesth
Ano de publicação:
2024
Tipo de documento:
Article